A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance
Open Access
- 25 November 2015
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 528 (7580) , 132-136
Abstract
Regulatory T cells need to express a diverse T-cell-receptor repertoire to control pathogenic self-reactive T cells; here it is shown that repertoire diversification depends on the intronic Foxp3 enhancer CNS3 acting at the regulatory T-cell-precursor stage to induce T-cell-receptor responsiveness to low-strength signals. Regulatory T cells (Treg cells) need to express a diverse T-cell receptor repertoire in order to control pathogenic self-reactive T cells that have survived negative selection in the thymus. Alexander Rudensky and colleagues show here that the repertoire diversification depends on the intronic Foxp3 enhancer conserved noncoding sequence 3 (CNS3), acting at the Treg precursor stage, to enable induction of the Foxp3 gene in response to low-strength T-cell-receptor signals. T-cell receptor (TCR) signalling has a key role in determining T-cell fate. Precursor cells expressing TCRs within a certain low-affinity range for complexes of self-peptide and major histocompatibility complex (MHC) undergo positive selection and differentiate into naive T cells expressing a highly diverse self-MHC-restricted TCR repertoire. In contrast, precursors displaying TCRs with a high affinity for ‘self’ are either eliminated through TCR-agonist-induced apoptosis (negative selection)1 or restrained by regulatory T (Treg) cells, whose differentiation and function are controlled by the X-chromosome-encoded transcription factor Foxp3 (reviewed in ref. 2). Foxp3 is expressed in a fraction of self-reactive T cells that escape negative selection in response to agonist-driven TCR signals combined with interleukin 2 (IL-2) receptor signalling. In addition to Treg cells, TCR-agonist-driven selection results in the generation of several other specialized T-cell lineages such as natural killer T cells and innate mucosal-associated invariant T cells3. Although the latter exhibit a restricted TCR repertoire, Treg cells display a highly diverse collection of TCRs4,5,6. Here we explore in mice whether a specialized mechanism enables agonist-driven selection of Treg cells with a diverse TCR repertoire, and the importance this holds for self-tolerance. We show that the intronic Foxp3 enhancer conserved noncoding sequence 3 (CNS3) acts as an epigenetic switch that confers a poised state to the Foxp3 promoter in precursor cells to make Treg cell lineage commitment responsive to a broad range of TCR stimuli, particularly to suboptimal ones. CNS3-dependent expansion of the TCR repertoire enables Treg cells to control self-reactive T cells effectively, especially when thymic negative selection is genetically impaired. Our findings highlight the complementary roles of these two main mechanisms of self-tolerance.Keywords
This publication has 42 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Endogenous antigen tunes the responsiveness of naive B cells but not T cellsNature, 2012
- Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cellsProceedings of the National Academy of Sciences, 2011
- T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouseJournal of Experimental Medicine, 2011
- Suppression of inflammation by a synthetic histone mimicNature, 2010
- Differential expression analysis for sequence count dataGenome Biology, 2010
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fateNature, 2010
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responsesNature, 2009
- How the thymus designs antigen-specific and self-tolerant T cell receptor sequencesProceedings of the National Academy of Sciences, 2008
- An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoiresNature Immunology, 2006